298 related articles for article (PubMed ID: 18632844)
1. Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy.
Zheng S; Carlson EC; Yang L; Kralik PM; Huang Y; Epstein PN
J Am Soc Nephrol; 2008 Nov; 19(11):2077-85. PubMed ID: 18632844
[TBL] [Abstract][Full Text] [Related]
2. Podocyte-specific overexpression of metallothionein mitigates diabetic complications in the glomerular filtration barrier and glomerular histoarchitecture: a transmission electron microscopy stereometric analysis.
Carlson EC; Chhoun JM; Laturnus DI; Bikash KC; Berg B; Zheng S; Epstein PN
Diabetes Metab Res Rev; 2013 Feb; 29(2):113-24. PubMed ID: 22926941
[TBL] [Abstract][Full Text] [Related]
3. Renoprotection From Diabetic Complications in OVE Transgenic Mice by Endothelial Cell Specific Overexpression of Metallothionein: A TEM Stereological Analysis.
Carlson EC; Chhoun JM; Grove BD; Laturnus DI; Zheng S; Epstein PN; Tan Y
Anat Rec (Hoboken); 2017 Mar; 300(3):560-576. PubMed ID: 27813325
[TBL] [Abstract][Full Text] [Related]
4. Metallothionein over-expression in podocytes reduces adriamycin nephrotoxicity.
Yang L; Zheng S; Epstein PN
Free Radic Res; 2009 Feb; 43(2):174-82. PubMed ID: 19204870
[TBL] [Abstract][Full Text] [Related]
5. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
[TBL] [Abstract][Full Text] [Related]
6. Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury.
Hong Q; Zhang L; Das B; Li Z; Liu B; Cai G; Chen X; Chuang PY; He JC; Lee K
Kidney Int; 2018 Jun; 93(6):1330-1343. PubMed ID: 29477240
[TBL] [Abstract][Full Text] [Related]
7. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in progression of diabetic nephropathy in OVE26 type 1 diabetic mice.
Wang W; Jiang S; Tang X; Cai L; Epstein PN; Cheng Y; Sun W; Xu Z; Tan Y
Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165589. PubMed ID: 31678163
[TBL] [Abstract][Full Text] [Related]
9. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
Susztak K; Raff AC; Schiffer M; Böttinger EP
Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
[TBL] [Abstract][Full Text] [Related]
10. Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice.
Ku CH; White KE; Dei Cas A; Hayward A; Webster Z; Bilous R; Marshall S; Viberti G; Gnudi L
Diabetes; 2008 Oct; 57(10):2824-33. PubMed ID: 18647955
[TBL] [Abstract][Full Text] [Related]
11. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
12. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
13. Soluble RARRES1 induces podocyte apoptosis to promote glomerular disease progression.
Chen A; Feng Y; Lai H; Ju W; Li Z; Li Y; Wang A; Hong Q; Zhong F; Wei C; Fu J; Guan T; Liu B; Kretzler M; Lee K; He JC
J Clin Invest; 2020 Oct; 130(10):5523-5535. PubMed ID: 32634130
[TBL] [Abstract][Full Text] [Related]
14. Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice.
Zhang H; Schin M; Saha J; Burke K; Holzman LB; Filipiak W; Saunders T; Xiang M; Heilig CW; Brosius FC
Am J Physiol Renal Physiol; 2010 Jul; 299(1):F91-8. PubMed ID: 20375116
[TBL] [Abstract][Full Text] [Related]
15. The antioxidant silybin prevents high glucose-induced oxidative stress and podocyte injury in vitro and in vivo.
Khazim K; Gorin Y; Cavaglieri RC; Abboud HE; Fanti P
Am J Physiol Renal Physiol; 2013 Sep; 305(5):F691-700. PubMed ID: 23804455
[TBL] [Abstract][Full Text] [Related]
16. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Glomerular and Podocyte mRNA Profiles in Streptozotocin-Induced Diabetes.
Fu J; Wei C; Lee K; Zhang W; He W; Chuang P; Liu Z; He JC
J Am Soc Nephrol; 2016 Apr; 27(4):1006-14. PubMed ID: 26264855
[TBL] [Abstract][Full Text] [Related]
18. Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis.
Wang Y; Heilig K; Saunders T; Minto A; Deb DK; Chang A; Brosius F; Monteiro C; Heilig CW
Am J Physiol Renal Physiol; 2010 Jul; 299(1):F99-F111. PubMed ID: 20375117
[TBL] [Abstract][Full Text] [Related]
19. SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in
Korbut AI; Taskaeva IS; Bgatova NP; Muraleva NA; Orlov NB; Dashkin MV; Khotskina AS; Zavyalov EL; Konenkov VI; Klein T; Klimontov VV
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340263
[TBL] [Abstract][Full Text] [Related]
20. Early-onset diabetic E1-DN mice develop albuminuria and glomerular injury typical of diabetic nephropathy.
Hyvönen ME; Dumont V; Tienari J; Lehtonen E; Ustinov J; Havana M; Jalanko H; Otonkoski T; Miettinen PJ; Lehtonen S
Biomed Res Int; 2015; 2015():102969. PubMed ID: 26000279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
